CYP19A1 and breast cancer: The gene expression analyses of breast cancer tissue from patients neoadjuvant treated with the aromatase inhibitor exemestane revealed that approximately one-half of the 610 androgen-induced genes examined were increased in response to blocking aromatase activity [67].